Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories.

BACKGROUND The precise relationship between risk factor burden and prevalence of peripheral artery disease (PAD) in different vascular territories (PAD, carotid artery stenosis [CAS], and abdominal aortic aneurysms [AAAs]) is unclear. METHODS We investigated the association of modifiable risk factors (hypertension, hypercholesterolemia, smoking, diabetes, and sedentary lifestyle) with any and type-specific peripheral vascular disease (PVD) among 3.3 million patients in the U.S., aged 40 to 99, who underwent screening bilateral ankle brachial indices, carotid duplex ultrasound, and abdominal aortic ultrasound in the Life Line Screening program between 2004 and 2008. Multivariate logistic regression analysis was used to estimate the odds of disease in different risk factor categories. Population-attributable risk was calculated to estimate the proportion of disease that could be potentially ascribed to modifiable risk factors. RESULTS Among 3,319,993 participants, prevalence of any PVD was 7.51% (95% confidence interval [CI], 7.50%-7.53%). PAD was present in 3.56% (95% CI, 3.54%-3.58%), CAS in 3.94% (95% CI, 3.92%-3.96%), and AAAs in 0.88% (95% CI, 0.86%-0.89%). The multivariate-adjusted prevalence with the presence of 0, 1, 2, 3, 4, and 5 modifiable risk factors was 2.76, 4.63, 7.12, 10.73, 16.00, and 22.08 (P < .0001 for trend) for any PVD; 1.18, 2.09, 3.28, 5.14, 8.32, and 12.43 (P < .0001 for trend) for PAD; 1.41, 2.36, 3.72, 5.73, 8.48, and 11.58 (P < .0001 for trend) for CAS; and 0.31, 0.54, 0.85, 1.28, 1.82, and 2.39 (P < .0001 for trend) for AAAs, respectively. These associations were similar for men and women. For every additional modifiable risk factor that was present, the multivariate-adjusted odds of having vascular disease increased significantly (any PVD [odds ratio (OR), 1.58; 95% CI, 1.58-1.59]; PAD [OR, 1.62; 95% CI, 1.62-1.63]; CAS [OR, 1.57; 95% CI, 1.56-1.57]; and AAA [OR, 1.51; 95% CI, 1.50-1.53]). CONCLUSIONS This very large contemporary database demonstrates that risk factor burden is associated with an increased prevalence of PVD, and there is a graded association between the number of risk factors present and the prevalence of PAD, CAS, and AAAs.

[1]  Danielle M. Enserro,et al.  Ideal Cardiovascular Health: Associations With Biomarkers and Subclinical Disease and Impact on Incidence of Cardiovascular Disease in the Framingham Offspring Study , 2014, Circulation.

[2]  A. Moskowitz,et al.  A Model for Predicting the Risk of Carotid Artery Disease , 2013, Annals of surgery.

[3]  Beatrice A. Golomb,et al.  Peripheral Arterial Disease: Morbidity and Mortality Implications , 2006, Circulation.

[4]  Peter Libby,et al.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.

[5]  C. Rockman,et al.  Focused screening for occult carotid artery disease: patients with known heart disease are at high risk. , 2004, Journal of vascular surgery.

[6]  Farzad Mostashari,et al.  Deaths preventable in the U.S. by improvements in use of clinical preventive services. , 2010, American journal of preventive medicine.

[7]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[8]  Donald Lloyd-Jones,et al.  Screening for cardiovascular risk in asymptomatic patients. , 2010, Journal of the American College of Cardiology.

[9]  Donald M Berwick,et al.  The "Million Hearts" initiative--preventing heart attacks and strokes. , 2011, The New England journal of medicine.

[10]  Deepak L. Bhatt,et al.  Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease , 2009, Circulation.

[11]  S. Reis,et al.  Low Prevalence of “Ideal Cardiovascular Health” in a Community-Based Population: The Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study , 2011, Circulation.

[12]  S. Walter.  The estimation and interpretation of attributable risk in health research. , 1976, Biometrics.

[13]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[14]  A. Dyer,et al.  Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. , 2000, JAMA.

[15]  Avis J. Thomas,et al.  Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[16]  Stacey A. Kenfield,et al.  Smoking and smoking cessation in relation to mortality in women. , 2008, JAMA.

[17]  Rodney A. White,et al.  2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 guideline) , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  D. Mozaffarian,et al.  Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults A Scientific Statement From the American Heart Association Endorsed by the Preventive Cardiovascular Nurses Association and the Society of Behavioral Medicine , 2010 .

[19]  J. Lindholt,et al.  Long‐term benefit and cost‐effectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial , 2010, The British journal of surgery.

[20]  M. Criqui,et al.  Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? , 2008, Circulation.

[21]  Ersen B. Colkesen,et al.  Systematic review of guidelines on peripheral artery disease screening. , 2012, The American journal of medicine.

[22]  R Eugene Zierler,et al.  Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. , 2003, Radiology.

[23]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[24]  F. Hu,et al.  Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. , 2012, JAMA.

[25]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[26]  H. Takagi,et al.  A further meta-analysis of population-based screening for abdominal aortic aneurysm. , 2010, Journal of vascular surgery.

[27]  Lora E Burke,et al.  Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. , 2011, Circulation.

[28]  N. Bornstein,et al.  Vascular Risks of Asymptomatic Carotid Stenosis , 1991, Stroke.

[29]  Harald Darius,et al.  Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease , 2009, Circulation.